Plasma Levels of Intact and Cleaved Urokinase Receptor Decrease in HIV-1-Infected Patients Initiating Highly Active Antiretroviral Therapy (Q57609583)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Terese L Katzenstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Henrik Ullum

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Pedersen M

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Høyer-Hansen G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Gerstoft J

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Pedersen BK

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Immunology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

478-486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

The urokinase receptor is overexpressed in the AIDS dementia complex and other neurological manifestations

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Identification and characterization of urokinase receptors in natural killer cells and T-cell-derived lymphokine activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Virological and immunological profiles among patients with undetectable viral load followed prospectively for 24 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Peptide-derived antagonists of the urokinase receptor. affinity maturation by combinatorial chemistry, identification of functional epitopes, and inhibitory effect on cancer cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase plasminogen activator receptor (uPAR; CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Clinical significance of urokinase-type plasminogen activator receptor (uPAR) expression in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

uPA and uPAR in fibrinolysis, immunity and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Increased Circulating Levels of Interleukin-6 in HIV-seropositive Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

The potential biological and clinical significance of the soluble tumor necrosis factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Interleukin-6 Infusion During Human Endotoxaemia Inhibits In Vitro Release of the Urokinase Receptor from Peripheral Blood Mononuclear Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

The soluble D2D3(88-274) fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Amino-Terminal Fragment of Urokinase-Type Plasminogen Activator Inhibits HIV-1 Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2006.001768.X

10.1111/J.1365-3083.2006.001768.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16764702%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference